Glucocorticoid Receptor Inactivation in Hepatocytes Reveals Crucial Role in Glucose Metabolism

Scientists in Germany have made a groundbreaking discovery that inactivating the glucocorticoid receptor (GR) in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in diabetes. This finding has significant implications for the treatment of diabetes mellitus, as it suggests that liver-specific glucocorticoid antagonists could be beneficial in controlling diabetic hyperglycemia.

Key Takeaways:

  • Inactivating the GR in hepatocytes leads to fasting hypoglycemia, a condition characterized by low blood sugar levels during periods of fasting.
  • Adult mice with inactivated GR in hepatocytes exhibit normal blood sugar levels under basal conditions, but show hypoglycemia after prolonged starvation.
  • The absence of GR in hepatocytes limits the development of hyperglycemia in streptozotocin-induced diabetes mellitus, a model of type 1 diabetes.
  • The GR is essential for liver glucose metabolism during fasting, and its dysfunction leads to impaired gluconeogenesis, the process by which the liver produces glucose from non-carbohydrate sources.
  • The study's findings indicate that liver-specific glucocorticoid antagonists could be a novel therapeutic approach for treating diabetic hyperglycemia.
  • The researchers used Cre/loxP technology to specifically inactivate the GR gene in hepatocytes, a technique that has been used previously to study the role of GR in other tissues.

Statistics:

  • 50% of mutant mice die within the first 2 days after birth due to hypoglycemia.
  • Adult mice exhibit reduced expression of genes involved in gluconeogenesis.
  • Streptozotocin-induced diabetes mellitus is a model of type 1 diabetes used in the study.
  • The study's findings highlight the crucial role of GR function in maintaining normal glucose levels during fasting and in diabetic mice.
  • Gluconeogenesis is a key process in glucose metabolism, and impaired gluconeogenesis contributes to hyperglycemia in diabetes.

Sources:

  • Opherk, C., et al. (2004). Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. Mol Endocrinol, 18(6), 1346-1353.